CMS Launches Cell and Gene Therapy (CGT) Access Model for Medicaid Sickle Cell Patients

What You Should Know:  – The Centers for Medicare & Medicaid Services (CMS) launches its Cell and Gene Therapy (CGT) Access Model, a new approach to delivering cutting-edge treatments for people on Medicaid living with sickle cell disease.  – A total of 33 states, plus the District of Columbia and Puerto Rico, will participate in ... Read More

• Published date: 16-07-2025 04:20 AM